Maqhuzu, P. N., Kreuter, M., Bahmer, T., Kahn, N., Claussen, M., Holle, R., & Schwarzkopf, L. (2021). Cost drivers in the pharmacological treatment of interstitial lung disease. Respiratory research, 22, . https://doi.org/10.1186/s12931-021-01807-8
Chicago-Zitierstil (17. Ausg.)Maqhuzu, Phillen Nozibuyiso, Michael Kreuter, Thomas Bahmer, Nicolas Kahn, Martin Claussen, Rolf Holle, und Larissa Schwarzkopf. "Cost Drivers in the Pharmacological Treatment of Interstitial Lung Disease." Respiratory Research 22 (2021). https://doi.org/10.1186/s12931-021-01807-8.
MLA-Zitierstil (9. Ausg.)Maqhuzu, Phillen Nozibuyiso, et al. "Cost Drivers in the Pharmacological Treatment of Interstitial Lung Disease." Respiratory Research, vol. 22, 2021, https://doi.org/10.1186/s12931-021-01807-8.